(Q43631946)

English

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

scientific article published in July 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx (English)

1 reference

Europe PubMed Central

25 November 2017

chemoradiotherapy

0 references

1 reference

based on heuristic

inferred from title

oral squamous cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Glaser CM

1

1 reference

Europe PubMed Central

25 November 2017

Millesi W

2

1 reference

Europe PubMed Central

25 November 2017

Kornek GV

3

1 reference

Europe PubMed Central

25 November 2017

Lang S

4

1 reference

Europe PubMed Central

25 November 2017

Schüll B

5

1 reference

Europe PubMed Central

25 November 2017

Watzinger F

6

1 reference

Europe PubMed Central

25 November 2017

Selzer E

7

1 reference

Europe PubMed Central

25 November 2017

Lavey RS

8

1 reference

Europe PubMed Central

25 November 2017

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

25 November 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

25 November 2017

50

1 reference

Europe PubMed Central

25 November 2017

3

1 reference

Europe PubMed Central

25 November 2017

705-715

1 reference

Europe PubMed Central

25 November 2017

Preoperative Simultaneous Chemoradiotherapy in Locally Advanced Cancer of the Oral Cavity and Oropharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative concurrent chemoradiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Does initial haemoglobin level modify the efficacy of radiosensitizers? An analysis of the MRC misonidazole studies in head and neck cancer and cervix cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical radiobiology of squamous cell carcinoma of the oropharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A multivariate study of the prognosis of oral squamous cell carcinomas. Are blood group and hemoglobin new prognostic factors?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human erythropoietin in patients with ovarian carcinoma and anaemia secondary to cisplatin and carboplatin chemotherapy: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythropoietin reduces anemia and transfusions: A randomized trial with or without erythropoietin during chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of weekly subcutaneous recombinant human erythropoietin administration for chemotherapy-induced anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythropoietin increases hemoglobin in cancer patients during radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythropoietin increases hemoglobin during radiation therapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythropoietin for patients undergoing radiotherapy: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of the extent of parametrial involvement in patients with carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of the hypoxic subvolume on the survival of patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The significance of anemia in clinical radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced oxygen enhancement ratio at low doses of ionizing radiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxygenation predicts radiation response and survival in patients with cervix cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of a bovine hemoglobin preparation on the response of the FSaIIC fibrosarcoma to chemotherapeutic alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood transfusion and other risk factors for recurrence of cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901488-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(01)01488-2

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43631946&oldid=2101999000"